| Literature DB >> 34114111 |
Katarzyna Ćwiek1, Anna Woźniak-Biel2, Magdalena Karwańska1, Magdalena Siedlecka1, Christine Lammens3, Ana Rita Rebelo4, Rene S Hendriksen4, Maciej Kuczkowski1, Monika Chmielewska-Władyka1, Alina Wieliczko1.
Abstract
BACKGROUND: A plasmid-mediated mechanism of bacterial resistance to polymyxin is a serious threat to public health worldwide. The present study aimed to determine the occurrence of plasmid-mediated colistin resistance genes and to conduct the molecular characterization of mcr-positive Escherichia coli strains isolated from Polish poultry.Entities:
Keywords: Biofilm; Escherichia coli; MLST; Mcr-1; Multidrug resistance; Sequence type
Mesh:
Substances:
Year: 2021 PMID: 34114111 PMCID: PMC8324725 DOI: 10.1007/s42770-021-00538-8
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Occurrence of resistance genes to antimicrobial agents, resistance profiles, biofilm formation, and sequence types (STs) in mcr-1-positive Escherichia coli strains (n = 17)
White square — lack of resistance gene; black square — presence of resistance gene.
GEN, gentamicin; AMP, ampicillin; CTX, cefotaxime; CAZ, ceftazidime; MEM, meropenem; NAL, nalidixic acid; CIP, ciprofloxacin; CHL, chloramphenicol, AZM, azithromycin; CST, colistin; TET, tetracycline; TGC, tigecycline; SMX, sulfamethoxazole; TMP, trimethoprim.
Biofilm formation: + + + — strong biofilm former, + + — moderate biofilm former, + — weak biofilm former.
Minimal inhibitory concentration (MIC) (μg/ml) of mcr-1-positive Escherichia coli strains (n = 17)
| Origin | Strain | MIC value (µg/ml) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GEN | AMP | CTX | CAZ | MEM | NAL | CIP | CHL | AZM | CST | TET | TGC | SMX | TMP | ||
| Turkeys | RF1/17 | < | |||||||||||||
| RF2/17 | < | ||||||||||||||
| RP1/17 | < | ||||||||||||||
| RP2/17 | < | ||||||||||||||
| RP3/17 | < | ||||||||||||||
| AE02/18 | < | < | < | < | < | ||||||||||
| AE21/18 | < | < | < | < | < | ||||||||||
| AE178/20 | < | < | < | < | < | < | |||||||||
| AE342/20 | < | < | < | < | < | < | < | ||||||||
| Broilers | RW1/17 | < | |||||||||||||
| RW2/17 | < | ||||||||||||||
| RW3/17 | < | < | < | ||||||||||||
| AE64/18 | < | < | |||||||||||||
| AE71/18 | < | < | < | < | |||||||||||
| AE256/20 | < | < | < | < | < | < | |||||||||
| AE257/20 | < | < | < | < | < | < | |||||||||
| Geese | AE05/18 | < | < | < | |||||||||||
Bold — resistance to an antimicrobial agent; italics — susceptible to an antimicrobial agent.
GEN, gentamicin; AMP, ampicillin; CTX, cefotaxime; CAZ, ceftazidime; MEM, meropenem; NAL, nalidixic acid; CIP, ciprofloxacin; CHL, chloramphenicol; AZM, azithromycin; CST, colistin; TET, tetracycline; TGC, tigecycline; SMX, sulfamethoxazole; TMP, trimethoprim.
Fig. 1Antimicrobial susceptibility of the mcr-1 harboring E. coli strains (n = 17). GEN, gentamicin; AMP, ampicillin; CTX, cefotaxime; CAZ, ceftazidime; MEM, meropenem; NAL, nalidixic acid; CIP, ciprofloxacin; CHL, chloramphenicol; AZM, azithromycin; CST, colistin; TET, tetracycline; TGC, tigecycline; SMX, sulfamethoxazole; TMP, trimethoprim
Fig. 2Sequence types (STs) and MLST-based phylogenetic tree of mcr-1-positive E. coli isolates. The phylogenetic tree was constructed using the neighbor-joining method in MEGA 6.0 software
Fig. 3The nucleotide differences in adk allele between the new ST and the ST69 clonal complex (ST69 and ST408)